Skip to Main content Skip to Navigation
Journal articles

HACEK endocarditis: state-of-the-art

Abstract : The HACEK group of bacteria - Haemophilus parainfluenzae, Aggregatibacter spp. (A. actinomycetemcomitans, A. aphrophilus, A. paraphrophilus, and A. segnis), Cardiobacterium spp. (C. hominis, C. valvarum), Eikenella corrodens, and Kingella spp. (K. kingae, K. denitrificans) - are fastidious gram-negative bacteria, part of the normal microbiota of oral and upper respiratory tract in humans. Although their pathogenicity is limited, they are responsible for 1-3% of all infective endocarditis. HACEK endocarditis mostly affect patients with underlying heart disease or prosthetic valves, and are characterized by an insidious course, with a mean diagnosis delay of 1 month (Haemophilus spp.) to 3 months (Aggregatibacter and Cardiobacterium spp.). The advent of continuously monitored blood culture systems with enriched media has erased the need for extended incubation for the diagnosis of HACEK endocarditis. Medical treatment relies on third-generation cephalosporin, with a favorable outcome in 80-90% of cases, with or without cardiac surgery
Complete list of metadata

Cited literature [52 references]  Display  Hide  Download
Contributor : Laurent Jonchère Connect in order to contact the contributor
Submitted on : Friday, June 10, 2016 - 4:27:42 PM
Last modification on : Thursday, January 14, 2021 - 11:17:18 AM


HACEK endocarditis-1.pdf
Files produced by the author(s)



Matthieu Revest, Gérald Egmann, Vincent Cattoir, Pierre Tattevin. HACEK endocarditis: state-of-the-art. Expert Review of Anti-infective Therapy, Expert Reviews, 2016, 14 (5), pp.523-530. ⟨10.1586/14787210.2016.1164032⟩. ⟨hal-01296779⟩



Record views


Files downloads